21-44499856-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144991.3(TSPEAR):c.1937C>A(p.Thr646Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000374 in 1,602,370 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_144991.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPEAR | ENST00000323084.9 | c.1937C>A | p.Thr646Lys | missense_variant | Exon 12 of 12 | 1 | NM_144991.3 | ENSP00000321987.4 | ||
TSPEAR | ENST00000642437.1 | n.*1882C>A | non_coding_transcript_exon_variant | Exon 13 of 13 | ENSP00000496535.1 | |||||
TSPEAR | ENST00000642437.1 | n.*1882C>A | 3_prime_UTR_variant | Exon 13 of 13 | ENSP00000496535.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000221 AC: 5AN: 225868Hom.: 0 AF XY: 0.00000812 AC XY: 1AN XY: 123202
GnomAD4 exome AF: 0.00000345 AC: 5AN: 1450172Hom.: 0 Cov.: 31 AF XY: 0.00000139 AC XY: 1AN XY: 720478
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74364
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 21, 2024 | This sequence change replaces threonine, which is neutral and polar, with lysine, which is basic and polar, at codon 646 of the TSPEAR protein (p.Thr646Lys). This variant is present in population databases (rs782251764, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with TSPEAR-related conditions. Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt TSPEAR protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 01, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at